Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Eugia Pharma Specialities Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

EUGIA PHARMA SPECIALITIES LIMITED

www.aurobindo.com

All Companies ›

Telangana ›

Manufacturing of Chemical Products ›

EUGIA PHARMA SPECIALITIES LIMITED

Active

Updated: 15 Mar 2026

EUGIA PHARMA SPECIALITIES LIMITED is a pharmaceutical company focused on the development, manufacturing, and marketing of specialty generic pharmaceuticals. It offers a diverse portfolio of products including injectables and oral solids, primarily catering to the healthcare needs of various therapeutic areas and ensuring high-quality, affordable medicines for patients globally.

Eugia Pharma Specialities Limited, is an unlisted public company incorporated on 17 April, 2013. It is classified as a public limited company and is located in , Telangana. It's authorized share capital is INR 800.00 cr and the total paid-up capital is INR 621.01 cr.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Company size

Auth Capital

₹ 800.0 Cr

Paidup Capital

₹ 621.0 Cr

Revenue

₹ 3250-3500 cr

Key Metrics

** All rupee values in INR crores. Based on March 2025 numbers.

Total Revenue

4.39%

₹ 3,334.6

EBITDA

2.29%

₹ 1,437.2

Net Profit

6.85%

₹ 855.3

Networth

43.28%

₹ 2,827.4

Borrowings

-38.31%

₹ 1,030.1

Assets

4.45%

₹ 4,538.9

Gross Margin

1.06

73.7 %

Operating Margin

-0.56

44.0 %

Net Profit Margin

0.59

25.6 %

Return on Equity

-10.31

30.2 %

ROCE

-6.16

40.9 %

Debt to Equity

-0.49

0.4

Sales

Mar 2025

Net worth

Mar 2025

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (7)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Ragunathan Kannan	00523576	4 years
Director	Sundari Raviprasad Pisupati	01908852	4 years
Director	Yugandhar Puvvala	09379957	4 years
Director	Madan Mohan Reddy Mettu Shareholder	01284266	13 years
Director	Santhanam Subramanian	03516515	4 years
Director	Veerayya Chowdary Kosaraju	08485334	4 years

Financial Highlights

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	402.3	1,702.2	2,014.4	3,150.9	3,264.0
Operating profit	119.6	575.4	659.0	1,405.0	1,437.2
Net profit	0.2	367.1	267.8	800.4	855.3
Gross margin	60.5	64.5	65.7	72.7	73.7
Operating margin	29.7	33.8	32.7	44.6	44.0
Net margin	0.0	20.8	13.0	25.1	25.6
Networth	919.1	905.7	1,173.8	1,973.3	2,827.4
Borrowings	311.5	890.0	1,997.0	1,669.8	1,030.1
Assets	1,557.6	3,189.4	4,041.1	4,345.5	4,538.9
Debt to equity	0.3	1.0	1.7	0.8	0.4
Current ratio	1.3	1.1	2.3	1.6	2.9
ROE	0.0	40.5	22.8	40.6	30.2
Days payable	262.0	186.0	180.0	194.0	172.0
WC days	94.0	39.0	181.0	93.0	147.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	621.0	621.0	621.0	621.0	621.0
Reserves	298.1	284.7	552.8	1,352.3	2,206.4
Borrowings +	311.5	890.0	1,997.0	1,669.8	1,030.1
Long term borrowings	267.9	890.0	1,997.0	986.3	825.0
Short term borrowings	43.6	-	-	683.5	205.1
Trade payables +	114.0	307.6	340.8	457.0	405.5
Days payable	262.0	186.0	180.0	194.0	172.0
Other liabilities +	213.1	1,086.1	529.6	245.4	275.8
Other non-current liabilities	3.1	37.2	125.7	151.8	186.9
Other current liabilities	210.0	1,048.9	403.8	93.6	89.0
Total liabilities	1,557.6	3,189.4	4,041.1	4,345.5	4,538.9
Fixed Assets +	990.3	1,544.1	1,808.8	1,700.5	1,636.2
Tangible assets	548.3	929.7	961.6	1,052.9	1,098.6
CWIP	376.8	524.0	481.9	363.0	328.8
Intangible assets	65.2	90.4	365.3	284.6	208.8
LT loans and advances	-	-	-	-	101.4
Other non-current assets	96.4	106.7	490.3	611.5	786.7
Current assets +	471.0	1,538.7	1,742.1	2,033.5	2,014.5
Inventories	225.9	497.9	578.2	713.5	727.9
Trade receivables	162.4	411.1	675.3	799.3	907.5
Cash and cash equivalents	0.2	112.8	120.6	47.3	75.0
ST loans and advances	-	2.1	1.7	2.0	2.8
Other current assets	82.5	514.8	366.3	471.4	301.3
Total assets	1,557.6	3,189.4	4,041.1	4,345.5	4,538.9

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	39.87	19.47	15.37	14.29	13.68
Reserves	19.14	8.93	13.68	31.12	48.61
Borrowings +	20.0	27.9	49.42	38.43	22.7
Long term borrowings	17.2	27.9	49.42	22.7	18.18
Short term borrowings	2.8	0.0	0.0	15.73	4.52
Trade payables	7.32	9.64	8.43	10.52	8.93
Other liabilities +	21.0	43.7	21.54	16.16	15.01
Other non-current liabilities	0.2	1.17	3.11	3.49	4.12
Other current liabilities	13.48	32.89	9.99	2.15	1.96
Total liabilities
Fixed Assets +	63.57	48.41	44.76	39.13	36.05
Tangible assets	35.2	29.15	23.8	24.23	24.2
CWIP	24.19	16.43	11.92	8.35	7.24
Intangible assets	4.19	2.83	9.04	6.55	4.6
LT loans and advances	0.0	0.0	0.0	0.0	2.24
Other non-current assets	6.19	3.34	12.13	14.07	17.33
Current assets +	30.24	48.24	43.11	46.8	44.38
Inventories	14.5	15.61	14.31	16.42	16.04
Trade receivables	10.43	12.89	16.71	18.39	19.99
Cash and cash equivalents	0.02	3.54	2.98	1.09	1.65
ST loans and advances	0.0	0.07	0.04	0.05	0.06
Other current assets	5.29	16.14	9.06	10.85	6.64
Total assets

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	621.0	621.0	621.0	621.0	621.0
Reserves	298.1	285.7	1,207.4	1,840.3	2,785.6
Borrowings +	307.7	990.5	2,366.0	2,149.9	1,520.4
Long term borrowings	264.1	989.5	2,366.0	1,466.4	1,262.6
Short term borrowings	43.6	1.0	-	683.5	257.8
Trade payables +	220.0	353.3	693.1	778.2	747.6
Days payable	294.0	175.0	237.0	198.0	162.0
Other liabilities +	1,576.0	1,454.5	477.3	581.5	463.0
Other non-current liabilities	11.3	45.7	236.5	165.8	215.9
Other current liabilities	1,564.6	1,408.8	240.7	415.7	247.2
Total liabilities	3,022.7	3,704.9	5,364.8	5,970.9	6,137.6
Fixed Assets +	1,583.2	1,854.4	3,045.3	2,548.8	2,564.4
Tangible assets	1,098.4	1,132.2	1,215.3	1,613.6	1,663.0
CWIP	419.6	631.8	1,385.1	553.9	597.4
Intangible assets	65.2	90.4	444.9	381.3	304.0
LT loans and advances	0.4	0.1	0.1	0.1	0.2
Other non-current assets	104.9	48.6	285.6	715.7	349.4
Current assets +	1,334.2	1,801.8	2,033.8	2,706.2	3,223.6
Inventories	558.5	563.6	874.9	1,110.0	1,120.6
Trade receivables	659.9	526.5	439.0	838.9	820.3
Cash and cash equivalents	0.3	190.7	231.1	196.0	656.5
ST loans and advances	2.2	2.4	2.0	2.3	3.4
Other current assets	113.2	518.6	486.8	559.0	622.7
Total assets	3,022.7	3,704.9	5,364.8	5,970.9	6,137.6

Percentage of assets	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	20.54	16.76	11.58	10.4	10.12
Reserves	9.86	7.71	22.51	30.82	45.39
Borrowings +	10.18	26.73	44.1	36.01	24.77
Long term borrowings	8.74	26.71	44.1	24.56	20.57
Short term borrowings	1.44	0.03	0.0	11.45	4.2
Trade payables	7.28	9.54	12.92	13.03	12.18
Other liabilities +	59.41	48.79	21.82	22.77	19.73
Other non-current liabilities	0.37	1.23	4.41	2.78	3.52
Other current liabilities	51.76	38.03	4.49	6.96	4.03
Total liabilities
Fixed Assets +	52.38	50.05	56.76	42.69	41.78
Tangible assets	36.34	30.56	22.65	27.02	27.1
CWIP	13.88	17.05	25.82	9.28	9.73
Intangible assets	2.16	2.44	8.29	6.39	4.95
LT loans and advances	0.01	0.0	0.0	0.0	0.0
Other non-current assets	3.47	1.31	5.32	11.99	5.69
Current assets +	44.14	48.63	37.91	45.32	52.52
Inventories	18.48	15.21	16.31	18.59	18.26
Trade receivables	21.83	14.21	8.18	14.05	13.37
Cash and cash equivalents	0.01	5.15	4.31	3.28	10.7
ST loans and advances	0.07	0.07	0.04	0.04	0.06
Other current assets	3.75	14.0	9.07	9.36	10.15
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales +	402.3	1,702.2	2,014.4	3,150.9	3,264.0
Sales growth %	183.02	323.14	18.34	56.42	3.59
Expenses +	404.8	1,301.3	1,695.7	2,116.0	2,172.2
Cost of goods	159.0	605.2	690.9	861.9	858.1
Employee cost	55.7	182.5	211.0	262.7	317.9
Other costs	68.0	339.1	453.5	621.4	650.9
Operating profit +	119.6	575.4	659.0	1,405.0	1,437.2
Operating margin %	29.7	33.8	32.7	44.6	44.0
Other income	3.6	64.9	40.0	43.3	70.6
Interest	39.5	40.5	129.1	141.8	115.6
Depreciation	82.7	134.0	211.3	228.3	229.7
Exceptional items	-	-	-	-	-
Profit before tax	1.1	465.8	358.6	1,078.3	1,162.4
Tax	0.9	98.7	90.8	277.8	307.2
Profit - disc. ops	-	-	-	-	-
Net profit	0.2	367.1	267.8	800.4	855.3
Net margin %	0.0	20.8	13.0	25.1	25.6

Precentage of total income	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	99.11	96.33	98.06	98.64	97.88
Expenses +	99.74	73.64	82.54	66.24	65.14
Cost of goods	39.18	34.25	33.63	26.98	25.73
Employee cost	13.71	10.33	10.27	8.22	9.53
Other costs	16.75	19.19	22.07	19.45	19.52
Operating profit	29.47	32.56	32.08	43.99	43.1
Other income	0.89	3.67	1.94	1.36	2.12
Interest	9.73	2.29	6.28	4.44	3.47
Depreciation	20.37	7.58	10.29	7.15	6.89
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.26	26.36	17.46	33.76	34.86
Tax	0.23	5.58	4.42	8.7	9.21
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	0.04	20.77	13.04	25.06	25.65

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales +	805.8	1,944.9	2,811.4	4,293.5	4,744.1
Sales growth %	None	141.36	44.55	52.72	10.49
Expenses +	644.2	1,552.2	2,433.6	3,129.7	3,605.3
Cost of goods	273.1	737.2	1,069.3	1,432.0	1,680.7
Employee cost	97.5	220.9	319.0	398.5	494.0
Other costs	156.8	397.6	673.3	889.6	991.2
Operating profit +	278.3	589.3	749.8	1,573.4	1,578.2
Operating margin %	34.5	30.3	26.7	36.6	33.3
Other income	3.6	68.4	17.1	33.5	84.6
Interest	39.5	40.5	129.4	145.0	143.0
Depreciation	77.3	156.1	242.6	264.5	296.4
Exceptional items	-	-	-	-281.7	-12.7
Profit before tax	165.2	461.1	394.9	915.7	1,210.7
Tax	0.9	99.8	99.2	292.2	278.9
Profit - disc. ops	-	-	-	-	-
Net profit	164.3	361.4	295.7	623.5	931.9
Net margin %	20.3	17.9	10.4	14.4	19.3

Precentage of total income	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	99.55	96.6	99.39	99.23	98.25
Expenses +	79.59	77.1	86.04	72.33	74.66
Cost of goods	33.74	36.61	37.81	33.09	34.81
Employee cost	12.05	10.97	11.28	9.21	10.23
Other costs	19.38	19.75	23.8	20.56	20.53
Operating profit	34.39	29.27	26.51	36.36	32.68
Other income	0.45	3.4	0.61	0.77	1.75
Interest	4.88	2.01	4.58	3.35	2.96
Depreciation	9.55	7.75	8.58	6.11	6.14
Exceptional items	0.0	0.0	0.0	-6.51	-0.26
Profit before tax	20.41	22.9	13.96	21.16	25.07
Tax	0.11	4.95	3.51	6.75	5.78
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	20.3	17.95	10.45	14.41	19.3

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Solvency +
Total Debt/Equity	0.3	1.0	1.7	0.8	0.4
Net Debt/Equity	0.3	0.9	1.6	0.8	0.3
Total Debt/Assets	0.2	0.3	0.5	0.4	0.2
Total Assets/Equity	1.7	3.5	3.4	2.2	1.6
Liquidity +
Current Ratio	1.3	1.1	2.3	1.6	2.9
Quick Ratio	0.7	0.8	1.6	1.1	1.8
Interest Coverage	3.0	14.2	5.1	9.9	12.4
Performance
Gross Margin	60.5	64.5	65.7	72.7	73.7
Operating Margin	29.7	33.8	32.7	44.6	44.0
Net Margin	0.0	20.8	13.0	25.1	25.6
Return +
Return on Equity	0.0	40.5	22.8	40.6	30.2
Pre-tax ROCE	3.4	25.6	15.9	47.1	40.9
Return on Assets	0.0	11.5	6.6	18.4	18.8
Pre-tax ROIC	3.0	26.2	14.7	32.7	31.9
Efficiency +
Days Payable	262.0	186.0	180.0	194.0	172.0
Days Inventory	518.0	300.0	305.0	302.0	310.0
Days Receivable	147.0	88.0	122.0	93.0	101.0
Fixed Asset Turnover	0.4	1.1	1.1	1.9	2.0
Total Asset Turnover	0.3	0.5	0.5	0.7	0.7
Working Capital
Cash Conversion Cycle	403.0	202.0	247.0	201.0	239.0
Working Capital Days	94.0	39.0	181.0	93.0	147.0

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Solvency +
Total Debt/Equity	0.3	1.1	1.3	0.9	0.5
Net Debt/Equity	0.3	0.9	1.2	0.8	0.2
Total Debt/Assets	0.1	0.3	0.4	0.4	0.2
Total Assets/Equity	3.3	4.1	2.9	2.4	1.8
Liquidity +
Current Ratio	0.7	1.0	2.2	1.4	2.6
Quick Ratio	0.4	0.7	1.2	0.8	1.7
Interest Coverage	7.0	14.5	5.8	10.8	11.0
Performance
Gross Margin	66.1	62.1	62.0	66.7	64.6
Operating Margin	34.5	30.3	26.7	36.6	33.3
Net Margin	20.3	17.9	10.4	14.4	19.3
Return +
Return on Equity	17.9	39.9	16.2	25.3	27.4
Pre-tax ROCE	18.5	22.9	12.2	38.8	28.3
Return on Assets	5.4	9.8	5.5	10.4	15.2
Pre-tax ROIC	16.4	25.4	12.8	29.6	30.0
Efficiency +
Days Payable	294.0	175.0	237.0	198.0	162.0
Days Inventory	746.0	279.0	299.0	283.0	243.0
Days Receivable	299.0	99.0	57.0	71.0	63.0
Fixed Asset Turnover	0.5	1.1	0.9	1.7	1.9
Total Asset Turnover	0.3	0.5	0.5	0.7	0.8
Working Capital
Cash Conversion Cycle	751.0	203.0	119.0	156.0	144.0
Working Capital Days	-224.0	7.0	143.0	70.0	152.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
TRUST AMC TRUSTEE PRIVATE LIMITED	Active	50.0 L	1	Maharashtra
PREMIER ENERGIES LIMITED	Active	45.1 Cr	1	Telangana
PRAVESHA INDUSTRIES PRIVATE LIMITED	Active	14.8 Cr	1
SATHGURU MANAGEMENT CONSULTANTS PVT LTD	Active	30.0 L	1	Telangana
FERNANDEZ FOUNDATION	Active	24.0 L	1	Telangana
PREMIER ENERGIES INTERNATIONAL PRIVATE LIMITED	Active	2.2 Cr	1	Telangana
SATHGURU SOFTWARE PRODUCTS PRIVATE LIMITED	Active	8.8 Cr	1	Telangana
OREMSI PLASTICS PRIVATE LIMITED	Strike Off	1.3 L	1	Telangana
CUREPRO PARENTERALS LIMITED	Amalgamated	13.3 Cr	1	Telangana
THERANYM BIOLOGICS PRIVATE LIMITED	Active	10.0 L	2	Telangana
AUROZEST PRIVATE LIMITED	Active	10.0 L	1	Telangana
AURO VACCINES PRIVATE LIMITED	Active	10.0 L	1	Telangana
CREST EXCIPIENTS LLP	Strike Off	1.3 L	1	Telangana
CURATEQ BIOLOGICS PRIVATE LIMITED	Active	102.1 Cr	1	Telangana
EUGIA SEZ PRIVATE LIMITED	Active	4.0 Cr	2	Telangana
MMR FAMILY ADVISORS PRIVATE LIMITED	Active	1.0 L	1	Telangana
AUROBINDO PHARMA LTD	Active	58.1 Cr	1	Telangana
EUGIA STERILES PRIVATE LIMITED	Active	44.2 Cr	2	Telangana
AURONEXT PHARMA PRIVATE LIMITED	Amalgamated	125.0 Cr	1	Telangana
RAINBOW CHILDREN'S MEDICARE LIMITED	Active	101.6 Cr	1	Telangana
RAINBOW SPECIALITY HOSPITALS PRIVATE LIMITED	Active	18.0 Cr	1	Telangana
PRATIKSHA WOMEN & CHILD CARE HOSPITAL PRIVATE LIMITED	Active	46.7 Cr	1	Assam
TERGENE BIOTECH LIMITED	Active	47.1 Cr	1	Telangana
AUROACTIVE PHARMA PRIVATE LIMITED	Active	247.0 Cr	1	Telangana
QULE PHARMA PRIVATE LIMITED	Active	10.0 L	1	Andhra Pradesh
LYFIUS PHARMA PRIVATE LIMITED	Active	10.0 L	1	Andhra Pradesh
APITORIA PHARMA PRIVATE LIMITED	Active	99.0 Cr	1	Telangana
GENOME FOUNDATION	Active	81.5 L	1	Telangana
GMR VARALAKSHMI FOUNDATION	Active	0.0	1	Andhra Pradesh
CCL PRODUCTS (INDIA) LIMITED	Active	26.7 Cr	1	Andhra Pradesh
DIVI'S LABORATORIES LIMITED	Active	53.1 Cr	1	Telangana
ANANT RAJ LIMITED	Active	72.0 Cr	1	Haryana
MY HOME INDUSTRIES PRIVATE LIMITED	Active	51.0 Cr	2	Telangana
NUZIVEEDU SEEDS LIMITED	Active	86.3 Cr	1	Telangana
YASHODA HEALTHCARE SERVICES LIMITED	Active	184.0 Cr	1	Telangana
RELIANCE JIO INFOCOMM LIMITED	Active	154,125.0 Cr	1	Gujarat
RELIANCE INDUSTRIES LIMITED	Active	13,532.5 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
EUGIA SEZ PRIVATE LIMITED	Telangana	2021	₹ 4.0 Cr
Eugia US LLC	United States	-	-
EUGIA STERILES PRIVATE LIMITED	Telangana	2020	₹ 44.2 Cr
Eugia Pharma B.V	Netherlands	-	-
Eugia pharma (malta) limited	Malta	-	-
Eugia (uk) limited	United Kingdom	-	-
Eugia Pharma Inc Canada	Canada	-	-
Eugia Pharma (Austalia) PTY Limited	Australia	-	-
Eugia pharma industria farmaceutica limitada	Brazil	-	-
Eugia Inc	United States	-	-
Eugia pharma colombia SAS	Colombia	-	-
Eugia US Manufacturing LLC	United States	-	-

Tofler Score

Very Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

HIGH INVENTORY

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U24297TG2013PLC087048

PAN

AADCE3429K

Incorporation

2013, 12.9 years

Company Email

cs@eugiapharma.com

Paid up Capital

₹ 621.0 Cr

Authorised Capital

₹ 800.0 Cr

AGM

Jul 2024

Type

Public

Others

FAQ - EUGIA PHARMA SPECIALITIES LIMITED

What is the incorporation date of EUGIA PHARMA SPECIALITIES LIMITED?

The incorporation date of EUGIA PHARMA SPECIALITIES LIMITED is 17 April, 2013

What is the authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED?

The authorized share capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 800.0 Cr.

What is the paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED?

The paid-up capital of EUGIA PHARMA SPECIALITIES LIMITED is INR ₹ 621.0 Cr.

What is the registered address of EUGIA PHARMA SPECIALITIES LIMITED?

The registered address of EUGIA PHARMA SPECIALITIES LIMITED is Plot No.2, Maitrivihar, Hyderabad, Ameerpet, Telangana, India, 500038 - 500038

What is the CIN number of EUGIA PHARMA SPECIALITIES LIMITED?

The CIN number of EUGIA PHARMA SPECIALITIES LIMITED is U24297TG2013PLC087048.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

EUGIA PHARMA SPECIALITIES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Company Network